Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
149 |
|
| Actual shortage: | 20 (13%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 125 (84%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 1 (20%) | |
| Discontinued: | 4 (80%) | |
| Reversed: | 0 (0%) | |
Late reports |
28 (18%) |
|
Overdue reports |
6 (27%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPIVACAINE INJECTION BP | 2.5MG | SOLUTION | Resolved | 2023-12-18 | 2024-12-20 | 213678 |
| BUPIVACAINE INJECTION BP | 2.5MG | SOLUTION | Resolved | 2023-12-18 | 2024-09-03 | 213681 |
| BUPIVACAINE INJECTION BP | 5MG | SOLUTION | Resolved | 2018-06-05 | 2020-07-08 | 51424 |
| BUPIVACAINE INJECTION BP | 5MG | SOLUTION | Resolved | 2019-05-27 | 2019-05-29 | 84853 |
| BUSULFAN FOR INJECTION | 6MG | SOLUTION | Resolved | 2019-07-26 | 2019-09-06 | 89991 |
| CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2018-05-03 | 2018-07-26 | 48190 |
| CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2019-07-19 | 2020-01-14 | 89647 |
| CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2022-03-03 | 2022-09-10 | 155959 |
| CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Actual shortage | 2024-02-01 | 2025-01-23 | 218148 |
| CALCITRIOL INJECTION USP | 2MCG | SOLUTION | Resolved | 2017-04-27 | 2021-08-11 | 8288 |
| CALCIUM CHLORIDE INJECTION BP | 100MG | SOLUTION | Resolved | 2022-06-15 | 2022-08-05 | 162674 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80085 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162207 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-02-14 | 182605 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Actual shortage | 2025-02-03 | 2025-03-27 | 249447 |
| CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80088 |
| CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-15 | 162210 |
| CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Actual shortage | 2025-02-03 | 2025-04-01 | 249450 |
| CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2017-05-03 | 2017-05-25 | 8810 |
| CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162221 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | Discontinued | 2024-01-15 | 2024-06-01 | 216017 |
| MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2024-01-22 | 2024-08-07 | 216963 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-03-22 | 2024-08-08 | 223140 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-03-22 | 2024-08-07 | 223145 |
| STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2025-04-10 | 2025-04-10 | 254712 |
Showing 1 to 5 of 5